<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">sredob</journal-id><journal-title-group><journal-title xml:lang="ru">Здоровье населения и среда обитания – ЗНиСО</journal-title><trans-title-group xml:lang="en"><trans-title>Public Health and Life Environment – PH&amp;LE</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-5238</issn><issn pub-type="epub">2619-0788</issn><publisher><publisher-name>ФБУЗ ФЦГиЭ Роспотребнадзора</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.35627/2219-5238/2023-31-4-22-29</article-id><article-id custom-type="elpub" pub-id-type="custom">sredob-1267</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВОПРОСЫ УПРАВЛЕНИЯ И СОЦИАЛЬНОЙ ГИГИЕНЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ISSUES OF MANAGEMENT AND SOCIAL HYGIENE</subject></subj-group></article-categories><title-group><article-title>COVID-19 и взаимосвязь с социальными и поведенческими факторами у населения Республики Казахстан</article-title><trans-title-group xml:lang="en"><trans-title>COVID-19 and Its Relationship with Social and Behavioral Factors in the Population of the Republic of Kazakhstan</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4773-0807</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Уразаева</surname><given-names>С. T,</given-names></name><name name-style="western" xml:lang="en"><surname>Urazayeva</surname><given-names>S. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Уразаева Салтанат Тураковна – кандидат медицинских наук, ассоциированный профессор, руководитель кафедры эпидемиологии»</p><p>ул. Маресьева, д. 68, г. Актобе, 030019</p></bio><bio xml:lang="en"><p>Saltanat T. Urazayeva, Cand. Sci. (Med.), Assoc. Prof., Head of Department of Epidemiology</p><p>68 Maresyev Street, Aktobe, 030019</p></bio><email xlink:type="simple">s.urazaeva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7141-9958</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кумар</surname><given-names>Г. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Kumar</surname><given-names>G. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кумар Гаухар Бердикуловна – магистрант 2-го года обучения специальности «Медико-профилактическое дело», кафедра эпидемиологии </p><p>ул. Маресьева, д. 68, г. Актобе, 030019</p></bio><bio xml:lang="en"><p>Gaukhar B. Kumar, 2nd year Master of Public Health and Preventive Medicine degree student, Department of Epidemiology</p><p>68 Maresyev Street, Aktobe, 030019</p></bio><email xlink:type="simple">gaukhar.kumar@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6980-378X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тусупкалиева</surname><given-names>К. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Tussupkaliyeva</surname><given-names>K. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тусупкалиева Кымбат Шариповна – кандидат медицинских наук, доцент кафедры эпидемиологии </p><p>ул. Маресьева, д. 68, г. Актобе, 030019</p></bio><bio xml:lang="en"><p>Kymbat Sh. Tussupkaliyeva, Cand. Sci. (Med.), Assoc. Prof., Department of</p><p>68 Maresyev Street, Aktobe, 030019</p></bio><email xlink:type="simple">kymbat1968@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4080-5383</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балмагамбетова</surname><given-names>С. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Balmagambetova</surname><given-names>S. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Балмагамбетова Сауле Кабиевна – доктор PhD, доцент кафедры онкологии</p><p>ул. Маресьева, д. 68, г. Актобе, 030019</p></bio><bio xml:lang="en"><p>Saule K. Balmagambetova, PhD, Assoc. Prof., Department of Oncology</p><p>68 Maresyev Street, Aktobe, 030019</p></bio><email xlink:type="simple">sau3567@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5978-2957</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Уразаева</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Urazayeva</surname><given-names>A. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Уразаева Айша Бауыржановна – доктор PhD, старший преподаватель кафедры эпидемиологии</p><p>ул. Маресьева, д. 68, г. Актобе, 030019</p></bio><bio xml:lang="en"><p>Aisha B. Urazayeva, PhD, Senior Lecturer, Department of Epidemiology</p><p>68 Maresyev Street, Aktobe, 030019</p></bio><email xlink:type="simple">aisha777.83@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3102-0499</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нурмаганбетова</surname><given-names>Г. Ж.</given-names></name><name name-style="western" xml:lang="en"><surname>Nurmaganbetova</surname><given-names>G. Zh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нұрмағанбетова Гүлайым Жаңбырбайкызы – м.м.н., старший преподаватель кафедры эпидемиологии</p><p>ул. Маресьева, д. 68, г. Актобе, 030019</p></bio><bio xml:lang="en"><p>Gulaiym Zh. Nurmaganbetova, Master of Medical Sciences, Senior Lecturer, Department of Epidemiology</p><p>68 Maresyev Street, Aktobe, 030019</p></bio><email xlink:type="simple">gul.aika@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5140-3545</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нурмухамедова</surname><given-names>Ш. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Nurmukhamedova</surname><given-names>Sh. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нурмухамедова Шара Маликовна – преподаватель кафедры эпидемиологии, магистр MBA</p><p>ул. Маресьева, д. 68, г. Актобе, 030019</p></bio><bio xml:lang="en"><p>Shara M. Nurmukhamedova, MBA, Lecturer, Department of Epidemiology</p><p>68 Maresyev Street, Aktobe, 030019</p></bio><email xlink:type="simple">shara_84@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4054-4347</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аманшиева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Amanshiyeva</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аманшиева Аймекен Аманжановна – преподаватель кафедры эпидемиологии, магистр MBA</p><p>ул. Маресьева, д. 68, г. Актобе, 030019</p></bio><bio xml:lang="en"><p>Aimeken A. Amanshiyeva, MBA, Lecturer, Department of Epidemiology</p><p>68 Maresyev Street, Aktobe, 030019</p></bio><email xlink:type="simple">aimeken.amanshieva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7708-2049</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ташимова</surname><given-names>Ж. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Tashimova</surname><given-names>Zh. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ташимова Жулдыз Кайргалиевна – старший преподаватель кафедры эпидемиологии, магистр MBA</p><p>ул. Маресьева, д. 68, г. Актобе, 030019</p></bio><bio xml:lang="en"><p>Zhuldyz K. Tashimova, MBA, Senior Lecturer, Department of Epidemiology</p><p>68 Maresyev Street, Aktobe, 030019</p></bio><email xlink:type="simple">zhulia_84@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НАО «Западно-Казахстанский медицинский университет имени Марата Оспанова»</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>West Kazakhstan Marat Ospanov State Medical University</institution><country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>02</day><month>05</month><year>2023</year></pub-date><volume>31</volume><issue>4</issue><fpage>22</fpage><lpage>29</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Уразаева С.T., Кумар Г.Б., Тусупкалиева К.Ш., Балмагамбетова С.К., Уразаева А.Б., Нурмаганбетова Г.Ж., Нурмухамедова Ш.М., Аманшиева А.А., Ташимова Ж.К., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Уразаева С.T., Кумар Г.Б., Тусупкалиева К.Ш., Балмагамбетова С.К., Уразаева А.Б., Нурмаганбетова Г.Ж., Нурмухамедова Ш.М., Аманшиева А.А., Ташимова Ж.К.</copyright-holder><copyright-holder xml:lang="en">Urazayeva S.T., Kumar G.B., Tussupkaliyeva K.S., Balmagambetova S.K., Urazayeva A.B., Nurmaganbetova G.Z., Nurmukhamedova S.M., Amanshiyeva A.A., Tashimova Z.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://zniso.fcgie.ru/jour/article/view/1267">https://zniso.fcgie.ru/jour/article/view/1267</self-uri><abstract><sec><title>Введение</title><p>Введение. В условиях продолжающейся пандемии COVID-19 информация о факторах риска заражения имеет исключительную актуальность. Целью нашего исследования был анализ распространенности поведенческих и со- циальных факторов риска заражения COVID-19.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведено перекрестное исследование среди 1123 жителей Казахстана в возрасте от 18 до 69 лет в период с октября по ноябрь 2021 года. Исследование проводилось с использованием стандартизи- рованной адаптированной анкеты STEPS, которая включала в себя социально-демографические данные, поведен- ческие данные и вопросы, связанные с COVID-19. Достоверность различий данных, характеризующих качественные признаки, определяли с помощью таблиц сопряженности 2×2 на основе значения критерия соответствия Пирсона χ2.</p></sec><sec><title>Результаты</title><p>Результаты. Средний возраст участников составил 44 года, среди них: мужчин – 29 %, женщин – 71 %. Молодые и люди среднего возраста болели чаще, чем люди старшего возраста (p &lt; 0,05). Чаще болели лица с высшим обра- зованием – 174 (55,6 %), чем лица с законченным средним образованием – 135 (43,1 %) (p &lt; 0,05). Среди больных участников было больше лиц, в семьях которых проживает от 1 до 3 человек (р &lt; 0,05), и большинство участников исследования не занимались умеренной физической нагрузкой. Статистически значимой связи между заболеванием и курением не выявлено (p &gt; 0,05). У переболевших были более высокие титры антител IgM и IgG, чем у здоровых. Наблюдалась значительная разница в заболеваемости между вакцинированными и невакцинированными (p &lt; 0,05) с ОШ 1661 (95 % ДИ 1275; 2164).</p></sec><sec><title>Заключение</title><p>Заключение. Результаты данного исследования могут служить ориентиром для информационных кампаний по профилактике COVID-19, проводимых органами здравоохранения и СМИ. Результаты данного исследования могут являться основой для проведения более углубленных исследований по оценке вклада различных факторов в фор- мирование уровня риска инфицирования COVID-19.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction: In the context of the ongoing COVID-19 pandemic, information about risk factors of the infection is of utmost importance. The objective of our study was to analyze the prevalence of behavioral and social risk factors for COVID-19.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: In October–November 2021, we conducted a cross-sectional study among 1,123 residents of Kazakhstan aged 18 to 69 years. We used a standardized customized STEPS questionnaire that included socio-demographic data, behavioral data, and questions related to COVID-19. The significance of differences in data characterizing qualitative features was determined using 2×2 contingency tables based on the value of Pearson’s χ2 correlation coefficient.</p></sec><sec><title>Results</title><p>Results: The mean age of the respondents was 44 years; 29 % of them were men and 71 % were women. Among those who had experienced COVID-19, there were more young and middle-aged people (p &lt; 0.05), people with higher education (55.6 %) (p &lt; 0.05), people having 1 to 3 family members (p &lt; 0.05), and those not engaged in moderate physical activity. We found no statistical relationship between smoking and the novel coronavirus disease (p &gt; 0.05). Those who recovered had higher titers of IgM and IgG antibodies. There was a considerable difference in disease incidence between the vaccinated and unvaccinated (p &lt; 0.05) with an odds ratio of 1.661 (95 % CI: 1.275; 2.164).</p></sec><sec><title>Conclusions</title><p>Conclusions: Our findings can serve as a guide for COVID-19 awareness campaigns aimed at the coronavirus disease prevention conducted by health authorities and mass media. They can also serve as the basis for in-depth studies of the contribution of various factors to the risk of the disease.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>COVID-19</kwd><kwd>эпидемиология</kwd><kwd>поведенческие</kwd><kwd>социальные факторы риска</kwd><kwd>опрос</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID 19</kwd><kwd>epidemiology</kwd><kwd>behavioral</kwd><kwd>social risk factors</kwd><kwd>survey</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Данное исследование выполнено за счет гранта научно-технической программы «Национальная программа внедрения персонализированной и превентивной медицины в Республике Казахстан», реализуемой КазНМУ имени С.Д. Асфендиярова в 2022–2024 годы. ИРН проекта: OR12165486.</funding-statement><funding-statement xml:lang="en">This research was conducted within the National Program for Implementation of Personalized and Preventive Medicine in the Republic of Kazakhstan 2022–2024 realized by Asfendiyarov Kazakh National Medical University, grant number OR12165486.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Updated WHO recommendations for international traffi in relation to COVID-19 outbreak. World Health Organization; 2020. Accessed June 23, 2020. https://www.who.int/news-room/articles-detail/updated-who-recommendations-for-international-traffic-in-relation-to-covid-19-outbrea</mixed-citation><mixed-citation xml:lang="en">Updated WHO recommendations for international traffi in relation to COVID-19 outbreak. World Health Organization; 2020. Accessed June 23, 2020. https://www.who.int/news-room/articles-detail/updated-who-recommendations-for-international-traffic-in-relation-to-covid-19-outbrea</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">WHO Coronavirus (COVID-19) Dashboard. URL: https://covid19.who.int/ (дата обращения: 23.06.2020).</mixed-citation><mixed-citation xml:lang="en">WHO Coronavirus (COVID-19) Dashboard. Accessed June 23, 2020. https://covid19.who.int/</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Geldsetzer P. Use of rapid online surveys to assess people’s perceptions during infectious disease outbreaks: A cross-sectional survey on COVID-19. J Med Internet Res. 2020;22(4):e18790. doi: 10.2196/18790</mixed-citation><mixed-citation xml:lang="en">Geldsetzer P. Use of rapid online surveys to assess people’s perceptions during infectious disease outbreaks: A cross-sectional survey on COVID-19. J Med Internet Res. 2020;22(4):e18790. doi: 10.2196/18790</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ali SH, Foreman J, Capasso A, Jones AM, Tozan Y, DiClemente RJ. Social media as a recruitment platform for a nationwide online survey of COVID-19 knowledge, beliefs, and practices in the United States: methodology and feasibility analysis. BMC Med Res Methodol. 2020;20(1):116. doi: 10.1186/s12874-020-01011-0</mixed-citation><mixed-citation xml:lang="en">Ali SH, Foreman J, Capasso A, Jones AM, Tozan Y, DiClemente RJ. Social media as a recruitment platform for a nationwide online survey of COVID-19 knowledge, beliefs, and practices in the United States: methodology and feasibility analysis. BMC Med Res Methodol. 2020;20(1):116. doi: 10.1186/s12874-020-01011-0</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Уразаева С.Т., Кумар Г.Б., Тусупкалиева К.Ш. и др. Распространенность поведенческих факторов риска инфицирования COVID-19. Обзор литературы // Вестник КазНМУ. 2022. № 1. С. 466–477.</mixed-citation><mixed-citation xml:lang="en">Urazayeva ST, Kumar GB, Tussupkaliyeva KSh, et al. Prevalence of behavioral risk factors for COVID-19 infection. Literature review. Vestnik Kazakhskogo Natsional’nogo Meditsinskogo Universiteta. 2022;(1):466-477. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bello B, Useh U. COVID-19: are non-communicable diseases risk factors for its severity? Am J Health Promot. 2021;35(5):720-729. doi: 10.1177/0890117121990518</mixed-citation><mixed-citation xml:lang="en">Bello B, Useh U. COVID-19: are non-communicable diseases risk factors for its severity? Am J Health Promot. 2021;35(5):720-729. doi: 10.1177/0890117121990518</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Noncommunicable Disease Surveillance, Monitoring and Reporting. URL: https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps (дата обращения: 23.06.2020).</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Noncommunicable Disease Surveillance, Monitoring and Reporting. Accessed June 23, 2020. https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Leidman E, Duca LM, Omura JD, Proia K, Stephens JW, Sauber-Schatz EK. COVID-19 trends among persons aged 0–24 years – United States, March 1–December 12, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(3):88-94. doi: 10.15585/mmwr.mm7003e1</mixed-citation><mixed-citation xml:lang="en">Leidman E, Duca LM, Omura JD, Proia K, Stephens JW, Sauber-Schatz EK. COVID-19 trends among persons aged 0–24 years – United States, March 1–December 12, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(3):88-94. doi: 10.15585/mmwr.mm7003e1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ortolan A, Lorenzin M, Felicetti M, Doria A, Ramonda R. Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis. Int J Infect Dis. 2020;99:496-504. doi: 10.1016/j.ijid.2020.07.076</mixed-citation><mixed-citation xml:lang="en">Ortolan A, Lorenzin M, Felicetti M, Doria A, Ramonda R. Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis. Int J Infect Dis. 2020;99:496-504. doi: 10.1016/j.ijid.2020.07.076</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Alghamdi IG, Hussain II, Almalki SS, Alghamdi MS, Alghamdi MM, El-Sheemy MA. The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Int J Gen Med. 2014;7:417-423. doi: 10.2147/IJGM.S67061</mixed-citation><mixed-citation xml:lang="en">Alghamdi IG, Hussain II, Almalki SS, Alghamdi MS, Alghamdi MM, El-Sheemy MA. The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Int J Gen Med. 2014;7:417-423. doi: 10.2147/IJGM.S67061</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lakbar I, Luque-Paz D, Mege JL, Einav S, Leone M. COVID-19 gender susceptibility and outcomes: A systematic review. PLoS ONE. 2020;15(11):e0241827. doi: 10.1371/journal.pone.0241827</mixed-citation><mixed-citation xml:lang="en">Lakbar I, Luque-Paz D, Mege JL, Einav S, Leone M. COVID-19 gender susceptibility and outcomes: A systematic review. PLoS ONE. 2020;15(11):e0241827. doi: 10.1371/ journal.pone.0241827</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Li LQ, Huang T, Wang YQ, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577-583. doi: 10.1002/jmv.25757</mixed-citation><mixed-citation xml:lang="en">Li LQ, Huang T, Wang YQ, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577-583. doi: 10.1002/jmv.25757</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091</mixed-citation><mixed-citation xml:lang="en">Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2021;73(11):e4208–e4213. doi: 10.1093/cid/ciaa270</mixed-citation><mixed-citation xml:lang="en">Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2021;73(11):e4208–e4213. doi: 10.1093/cid/ciaa270</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 – COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–464. doi: 10.15585/mmwr.mm6915e3</mixed-citation><mixed-citation xml:lang="en">Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 – COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–464. doi: 10.15585/mmwr.mm6915e3</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29. doi: 10.1186/s13293-020-00304-9</mixed-citation><mixed-citation xml:lang="en">Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29. doi: 10.1186/s13293-020-00304-9</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bhopal SS, Bhopal R. Sex differential in COVID-19 mortality varies markedly by age. Lancet. 2020;396(10250):532-533. doi: 10.1016/S0140-6736(20)31748-7</mixed-citation><mixed-citation xml:lang="en">Bhopal SS, Bhopal R. Sex differential in COVID-19 mortality varies markedly by age. Lancet. 2020;396(10250):532-533. doi: 10.1016/S0140-6736(20)31748-7</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Griffith DM, Sharma G, Holliday CS, et al. Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions. Prev Chronic Dis. 2020;17:E63. doi: 10.5888/pcd17.200247</mixed-citation><mixed-citation xml:lang="en">Griffith DM, Sharma G, Holliday CS, et al. Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions. Prev Chronic Dis. 2020;17:E63. doi: 10.5888/pcd17.200247</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 2020;8(4):e20. doi: 10.1016/S2213-2600(20)30117-X</mixed-citation><mixed-citation xml:lang="en">Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 2020;8(4):e20. doi: 10.1016/S2213-2600(20)30117-X</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Valdes E, Fuchs B, Morrison C, et al. Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19. J Neurol Sci. 2022;438:120146. doi: 10.1016/j.jns.2022.120146</mixed-citation><mixed-citation xml:lang="en">Valdes E, Fuchs B, Morrison C, et al. Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19. J Neurol Sci. 2022;438:120146. doi: 10.1016/j.jns.2022.120146</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Попова А.Ю., Ежлова Е.Б., Мельникова А.А. и др. Популяционный иммунитет к SARS-CoV-2 среди населения Санкт-Петербурга в период эпидемии COVID-19 // Проблемы особо опасных инфекций. 2020. № 3. С. 124–130. doi: 10.21055/0370-1069-2020-3-124-130</mixed-citation><mixed-citation xml:lang="en">Popova AYu, Ezhlova EB, Mel'nikova AA, et al. Herd immunity to SARS-CoV-2 among the population in Saint-Petersburg during the COVID-19 epidemic. Problemy Osobo Opasnykh Infektsiy. 2020;(3):124-130. (In Russ.) doi: 10.21055/0370-1069-2020-3-124-130</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Haileamlak A. Physical inactivity: the major risk factor for non-communicable diseases. Ethiop J Health Sci. 2019;29(1):810. doi: 10.4314/ejhs.v29i1.1</mixed-citation><mixed-citation xml:lang="en">Haileamlak A. Physical inactivity: the major risk factor for non-communicable diseases. Ethiop J Health Sci. 2019;29(1):810. doi: 10.4314/ejhs.v29i1.1</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Robinson E, Boyland E, Chisholm A, et al. Obesity, eating behavior and physical activity during COVID-19 lockdown: A study of UK adults. Appetite. 2021;156:104853. doi: 10.1016/j.appet.2020.104853</mixed-citation><mixed-citation xml:lang="en">Robinson E, Boyland E, Chisholm A, et al. Obesity, eating behavior and physical activity during COVID-19 lockdown: A study of UK adults. Appetite. 2021;156:104853. doi: 10.1016/j.appet.2020.104853</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Gallo LA, Gallo TF, Young SL, Moritz KM, Akison LK. The impact of isolation measures due to COVID-19 on energy intake and physical activity levels in Australian university students. Nutrients. 2020;12(6):1865. doi: 10.3390/nu12061865</mixed-citation><mixed-citation xml:lang="en">Gallo LA, Gallo TF, Young SL, Moritz KM, Akison LK. The impact of isolation measures due to COVID-19 on energy intake and physical activity levels in Australian university students. Nutrients. 2020;12(6):1865. doi: 10.3390/nu12061865</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Eime R, Harvey J, Charity M, et al. The impact of COVID-19 restrictions on perceived health and wellbeing of adult Australian sport and physical activity participants. BMC Public Health. 2022;22(1):848. doi: 10.1186/s12889-022-13195-9</mixed-citation><mixed-citation xml:lang="en">Eime R, Harvey J, Charity M, et al. The impact of COVID-19 restrictions on perceived health and wellbeing of adult Australian sport and physical activity participants. BMC Public Health. 2022;22(1):848. doi: 10.1186/s12889-02213195-9</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Позднякова Маргарита Ефимовна, Брюно Виктория Владимировна Употребление алкоголя в России в условиях пандемии COVID-19 // СНиСП. 2022. Т. 10. № 3 (39). С. 25–44. (In Russ.) doi: 10.19181/snsp.2022.10.3.9195</mixed-citation><mixed-citation xml:lang="en">Pozdniakova ME, Bruno VV. Alcohol consumption in Russia during the COVID-19 pandemic. Sotsiologicheskaya Nauka i Sotsial’naya Praktika. 2022;10(3(39)):25-44. (In Russ.) doi: 10.19181/snsp.2022.10.3.9195</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Guignard R, Andler R, Quatremère G, et al. Changes in smoking and alcohol consumption during COVID-19-related lockdown: a cross-sectional study in France. Eur J Public Health. 2021;31(5):1076-1083. doi: 10.1093/eurpub/ckab054</mixed-citation><mixed-citation xml:lang="en">Guignard R, Andler R, Quatremère G, et al. Changes in smoking and alcohol consumption during COVID-19-related lockdown: a cross-sectional study in France. Eur J Public Health. 2021;31(5):1076-1083. doi: 10.1093/eurpub/ckab054</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Jackson SE, Garnett C, Shahab L, Oldham M, Brown J. Association of the COVID-19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data. Addiction. 2021;116(5):1233-1244. doi: 10.1111/add.15295</mixed-citation><mixed-citation xml:lang="en">Jackson SE, Garnett C, Shahab L, Oldham M, Brown J. Association of the COVID-19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data. Addiction. 2021;116(5):1233-1244. doi: 10.1111/add.15295</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Yu F, Le MQ, Inoue S, et al. Recombinant truncated nucleocapsid protein as antigen in a novel immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of severe acute respiratory syndrome coronavirus infection. Clin Vaccine Immunol. 2007;14(2):146-149. doi: 10.1128/CVI.00360-06</mixed-citation><mixed-citation xml:lang="en">Yu F, Le MQ, Inoue S, et al. Recombinant truncated nucleocapsid protein as antigen in a novel immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of severe acute respiratory syndrome coronavirus infection. Clin Vaccine Immunol. 2007;14(2):146-149. doi: 10.1128/CVI.00360-06</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Федоров Вячеслав Сергеевич, Иванова Ольга Николаевна, Карпенко Инна Леонидовна, Иванов Александр Владимирович Иммунный ответ на новую коронавирусную инфекцию // Клиническая практика. 2021. Т. 12. № 1. С. 33–40. doi: 10.17816/clinpract64677</mixed-citation><mixed-citation xml:lang="en">Fedorov VS, Ivanova ON, Karpenko IL, Ivanov AV. The immune response to the novel coronavirus infection. Klinicheskaya Praktika. 2021;12(1):33-40. (In Russ.) doi: 10.17816/clinpract64677</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Saeed AY, Assafi MS, Othman HE, Shukri HM. Prevalence of SARS-CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq. J Infect Dev Ctries. 2022;16(7):11261130. doi: 10.3855/jidc.15825</mixed-citation><mixed-citation xml:lang="en">Saeed AY, Assafi MS, Othman HE, Shukri HM. Prevalence of SARS-CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq. J Infect Dev Ctries. 2022;16(7):11261130. doi: 10.3855/jidc.15825</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou C, Bu G, Sun Y, et al. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay. J Med Virol. 2021;93(5):2857-2866. doi: 10.1002/jmv.26741</mixed-citation><mixed-citation xml:lang="en">Zhou C, Bu G, Sun Y, et al. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay. J Med Virol. 2021;93(5):2857-2866. doi: 10.1002/jmv.26741</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Papagoras C, Fragoulis GE, Zioga N, et al. Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases. Ann Pheum Dis. 2022; 81(7):1013-1016. doi: 10.1136/annrheum-dis-2021-221539</mixed-citation><mixed-citation xml:lang="en">Papagoras C, Fragoulis GE, Zioga N, et al. Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases. Ann Pheum Dis. 2022; 81(7):1013-1016. doi: 10.1136/annrheum-dis-2021-221539</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Peghin M, De Martino M, Palese A, et al. Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clin Microbiol Infect. 2022;28(8):1140-1148. doi: 10.1016/j.cmi.2022.03.016</mixed-citation><mixed-citation xml:lang="en">Peghin M, De Martino M, Palese A, et al. Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clin Microbiol Infect. 2022;28(8):1140-1148. doi: 10.1016/j.cmi.2022.03.016</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Сыров А.В., Стуров Н.В., Колупаев В.Е. Диагностика COVID-19 в амбулаторных условиях. Трудный пациент. 2020. Т. 18. № 5. С. 6–9. doi: 10.24411/2074-1995-2020-10031</mixed-citation><mixed-citation xml:lang="en">Syrov AV, Sturov NV, Kolupaev VE. Diagnosing COVID-19 in outpatient practice. Trudnyy Patsient. 2020;18(5):6-9. (In Russ.) doi: 10.24411/2074-1995-2020-10031</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
